| THC | Δ9-tetrahydrocannabinol |
| CBR | Cannabinoid receptor |
| AEA | N-arachidonoyl-ethanolamine |
| 2-AG | 2-arachidonoylglycerol |
| CBD | Cannabidiol |
| GPCR | G protein-coupled receptor |
| TRPV1 | Transient receptor potential cation channel subfamily V member 1 |
| NAPE | N-acyl-phosphatidylethanolamine |
| NAPE-PLD | NAPE-specific phospholipase D |
| DAG | Diacylglycerol |
| DAGL | DAG lipase |
| FAAH | Fatty acid amide hydrolase |
| MAGL | Monoacylglycerol lipase |
| CNS | Central nervous system |
| DSI | Depolarization-induced suppression of inhibition |
| DSE | Depolarization-induced suppression of excitation |
| LTD | Long-term depression |
| AC | Adenylyl cyclase |
| PNS | Peripheral nervous system |
| GI | Gastrointestinal |
| cAMP | Cyclic adenosine monophosphate |
| PTX | Pertussis toxin |
| WIN | WIN 55,212-2 |
| NMDAR | N-methyl-d-aspartate receptor |
| cDNA | Complementary deoxyribonucleic acid |
| GABA | γ-aminobutyric acid |
| GIRK | G-protein-coupled inwardly rectifying K+ channel |
| ERK1/2 | Extracellular signal-regulated kinase 1/2 |
| JNK | c-Jun N-terminal kinase |
| MAPK | Mitogen-activated protein kinase |
| PI3K | Phosphatidylinositol-3-kinases |
| BDNF | Brain-derived neurotrophic factor |
| NO | Nitric oxide |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| HD | Huntington’s disease |
| MSN | Medium spiny projection neuron |
| Htt | Huntingtin |